510(k) Report

510(k) · Cleared

Cleared

pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW 504

K233159510(k) TraditionalCleared Dec 1, 202365-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fresenius Medical Care Renal Therapies Group, LLC · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on Dec 1, 2023 as substantially equivalent to K162887 (Baxter Healthcare Corporation, 2017) after a 65-day review. Its family tree reaches back 8 generations to 1987. 3 later devices descend from it.

Decided
Dec 1, 2023
Review
65 days
Class
Class II
Product code
KPO
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K864265 (1987). 14 ancestors in all. 3 later devices descend from it, 2 citing it directly.

  1. Root · 8 generations backK864265 Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc. · 1987
  2. 7 generations backK013448 PrismasateGambro Renal Products · 2002
  3. 6 generations backK022913 Nxstage Premixed DialysateNxstage Medical, Inc. · 2002
  4. 5 generations backK033386 Nxstage Pureflow SolutionNxstage Medical, Inc. · 2003
  5. 4 generations backK042045 Nxstage Pureflow-B SolutionNxstage Medical, Inc. · 2004 · Recalled
  6. 3 generations backK072908 Prismasate Dialysis Solutions for Continuous Renal Replacement TherapyGambro Renal Products · 2008 · Recalled
  7. 2 generations backK120333 Prismasate Dialysis Solutions for Continuius Renal Replacement TherapyGambro Renal Products · 2012
  8. 1 generation backK162887 PrismaSATEBaxter Healthcare Corporation · 2017
  9. This deviceK233159 pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW…Fresenius Medical Care Renal Therapies Group, LLC · 2023
  10. Descendant · cites it directly · 2 of its ownK233950 pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401…Fresenius Medical Care Renal Therapies Group, LLC · 2024 · Recalled
  11. Descendant · cites it directly · 1 of its ownK243786 Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400…Fresenius Medical Care Renal Therapies Group, LLC · 2025 · Recalled
  12. Descendant · 2 generations on · 0 of its ownK252180 Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403…Fresenius Medical Care Renal Therapies Group, LLC · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW…Fresenius Medical Care Renal Therapies Group, LLC · 2024 · cites it directly2descendants
  • K243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby…Fresenius Medical Care Renal Therapies Group, LLC · 2025 · cites it directly1descendant
  • K252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby…Fresenius Medical Care Renal Therapies Group, LLC · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K864265Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc.1987—
−7K013448PrismasateGambro Renal Products2002—
−6K022913Nxstage Premixed DialysateNxstage Medical, Inc.2002—
−5K033386Nxstage Pureflow SolutionNxstage Medical, Inc.2003—
−4K042045Nxstage Pureflow-B SolutionNxstage Medical, Inc.20041
−3K072908Prismasate Dialysis Solutions for Continuous Renal Replacement TherapyGambro Renal Products20081
−2K120333Prismasate Dialysis Solutions for Continuius Renal Replacement TherapyGambro Renal Products2012—
−1K162887PrismaSATEBaxter Healthcare Corporation2017—
0 (this device)K233159pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW…Fresenius Medical Care Renal Therapies Group, LLC2023—
+1K233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069)…Fresenius Medical Care Renal Therapies Group, LLC20241
+1K243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G)…Fresenius Medical Care Renal Therapies Group, LLC20252
+2K252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W)…Fresenius Medical Care Renal Therapies Group, LLC2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
200010
200110
200210
200410
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
202520
FIG. 1 — Lineage of K233159, 1987–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K260799 Nipro Dry Acid Concentrate Mixerscore 13.1 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K162887PrismaSATE
Summary page 6
…gy/Urology 5.3. Legally Marketed Predicate Device The legally marketed predicate device for the proposed pureFLOW dialysis solutions is the PrismaSATE dialysate (K162887). This device is not currently subject to a design-related recall. The B.Braun Modified Duosol Bicarbonate Dialysate (K052393), N…
Baxter Healthcare Corporation2017—
†K052393B. Braun Modified Bicarbonate DialysateB.Braun Medical, Inc.2005—
†K053286Modification to: Nxstage Pureflow-B SolutionNxstage Medical, Inc.200514
†K212052HMB32 Dialysis SolutionHaemopharm Biofluids S.R.L.2021—

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW…Fresenius Medical Care Renal Therapies Group, LLC20242
K243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby…Fresenius Medical Care Renal Therapies Group, LLC20251

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 36 years and passes through 5 companies; a new generation was cleared every 4.3 years on median.
  • 2 of the 14 ancestors have a recall of any class.
  • Of its descendants, K233950 (Fresenius Medical Care Renal Therapies Group, LLC, 2024) has gone furthest, with 2 descendants of its own.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—

What is it indicated for?

pureFLOW solutions are indicated for use as a dialysate in Continuous Renal Replacement Therapy

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K233159: pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW 504.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K233159

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026